Participated · Series A · Jan 2025

Founded in 2021 in New York, Conceivable Life Sciences is building AURA, an integrated in-vitro fertilization (IVF) lab platform that combines AI, robotics, and advanced optics to automate and standardize over 200 manual procedures spanning oocyte and sperm preparation, fertilization, embryo culture, vitrification, and thawing. The system provides end-to-end sample traceability and uses proprietary imaging (e.g., OCT) and machine-learning models to guide robotic manipulators in real time. Initial prototype work has already resulted in the birth of 18 healthy babies, and the company is running a 100-patient clinical trial with plans to gather data from an additional 120 patients this year. In a pilot deployment at Hope IVF in Mexico City, a three-person team processed roughly 2,000 IVF cycles annually with AURA, illustrating meaningful throughput and labor savings. Management aims to complete clinical trials and launch full commercial operations in the United States in early 2026. After its recent financing, the company has raised a total of $70 million to date, positioning it to move from pilot projects to commercialization.

Participated · Series B · Apr 2024

Headquartered in Palo Alto, Midi Health operates a nationwide virtual clinic that addresses gaps in women’s healthcare from perimenopause and menopause to broader chronic and preventive needs. The company’s proprietary AI engine analyzes patient charts to personalize diagnosis, streamline scheduling and documentation, and continuously refine clinical protocols using one of the industry’s largest women’s-health datasets. Midi currently has insurance contracts that give more than 45 million U.S. women in-network access to its services, and over 25,000 patients seek care on the platform each week. Outcomes data show a 28-percentage-point increase in breast-cancer screening adherence, an 11-point rise in colorectal screening adherence, and up to a 13 percent reduction in total cost of care, alongside clinically significant reductions in A1c and LDL levels. The business complements its clinical model with an expanding specialist roster covering OB-GYN, cardiology, endocrinology, mood disorders, dermatology, longevity, and more. Recent executive hires from Tesla, Google, Meta, Lyft, and Omada Health signal a push to scale operations and brand awareness. Following its latest financing, Midi is valued at more than $1 billion and plans to broaden its AI capabilities and extend comprehensive women’s care across every life stage.

Participated · Equity · Jun 2023

Beekeeper’s Naturals is a Los Angeles, CA-based health and wellness company that creates products powered by propolis and backed by science. Led by founder Carly Stein Kremer and founded in 2017, the team applies scientific rigor and third-party pesticide testing to develop natural remedies addressing chronic stress, poor sleep, digestive issues and scratchy throats. Its flagship Propolis Throat Spray secured the #1 rank in Amazon’s Cold & Flu category and the brand became the fastest-growing in the Immune Support category at mass retail. The company reported triple-digit year-over-year growth and expanded retail distribution from 5,000 to over 18,000 locations across the U.S. and Canada in 2022. Beekeeper’s raised $14M in funding and intends to use the proceeds to accelerate retail and online growth and expand its innovation pipeline. The company emphasizes product efficacy and natural sourcing as central to its growth strategy. Beekeeper’s Naturals offers a product line of plant-based adaptogens and health-boosting complexes that incorporate superfoods straight from the hive. Its products target immune support, brain health, increased energy and sleep issues. The company plans to use new funding to further R&D to develop natural alternatives for the medicine cabinet and to expand retail distribution. The business was founded by Carly Stein (age 28) and is based in Toronto, ON. The article reports a $3.5M Series A raise led by Sonoma Brands to support these initiatives. No operating metrics or prior rounds are mentioned in the article.

Led · Seed · Apr 2023

Eli builds a palm-sized at-home testing system that measures minuscule amounts of hormones in saliva to provide daily hormonal data. The product targets unmet needs across menopause, fertility, contraception, and endocrine conditions by enabling continuous, timely hormone monitoring. Eli’s scientific and engineering breakthroughs stem from years of R&D to make continuous saliva monitoring accurate and affordable for long-term home use. The company says users collect a tiny saliva sample, insert it into the reader, and receive results in minutes via an app. The new funding will let Eli finalize product development and advance through clinical validation and regulatory approvals toward commercial launch. Since launching in 2019, Eli has raised a total of CAD $9 million, including a CAD $1.9 million pre-seed in 2020. Eli develops a saliva-based at-home device and companion app that capture hormone fluctuations and provide daily, personalized information based on each user’s evolving hormonal profile. The company positions its product to help women own their fertility and broader health decisions. Led by CEO and co-founder Marina Pavlovic Rivas, Eli combines hardware and software with clinical and academic partnerships. The company plans to use new capital for product development, clinical validations with independent medical centers, and initial strategic sales. Eli will continue collaborating with academic institutions to advance women’s health research. Financially, the company raised a seed round that increases its total funding since creation in mid-2019.

Participated · Seed · Jul 2022

Finli is a mobile-first payment management company based in San Marino, California, started nearly three years ago by CEO Lori Shao. Shao, who spent 20 years building mobile technology for fintechs and payment companies, built Finli to serve microbusinesses that still rely on checks and informal client records. The platform lets owners send invoices via email, SMS or other messaging apps, look up customer information, check payment status between gigs, and digitize client lists with a built-in CRM. Finli offers a freemium model and a Pro package starting at $25 per month that includes recurring payments and ACH direct debit; it charges zero merchant transaction fees for bank-to-bank transfers. The app also automatically reconciles cash and check payments and manages collections with automated emails and text messages. The company had 11 employees and grew from 500 business accounts at the end of 2021 to 3,000 six months later (about 500% growth); it plans to use new capital to grow the team and continue developing business banking features.